HomeNDC LookupRxCUI directory › RxCUI 721773

Clozapine 12.5 MG Disintegrating Oral Tablet — RxCUI 721773

RxNorm drug concept · Semantic clinical drug
RxCUI 721773 Semantic clinical drug · SCD ● Current RxNorm concept 10 FDA products 18 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI721773
Official nameClozapine 12.5 MG Disintegrating Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped10
Package NDCs mapped18
Reported Medicaid activity (SDUD)9,197 prescriptions · 23 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Clozapine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Clozapine is reserved for situations where other antipsychotics haven't provided enough relief. If you're taking it for schizophrenia, it means your care team determined that stand...
  • Why am I on clozapine instead of a regular antipsychotic?
  • This is genuinely one of the most important parts of being on clozapine. The medication can cause a dangerous drop in the white blood cells that fight infection — a condition calle...
  • Why do I have to get blood tests so often?
📖 Read our full Clozapine guide →

🕸️ Concept Web — How Clozapine 12.5 MG Disintegrating Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Clozapine 12.5 MG Disintegrating Oral Tablet RxCUI 721773

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Clozapine 2626
  2. Dose forms 8

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Clozapine Disintegrating Oral Tablet 476178
    • Clozapine Disintegrating Oral Product 1295568
    • Clozapine Oral Product 1153930
    • Clozapine Pill 1153931
    • Disintegrating Oral Tablet 316942
    • Disintegrating Oral Product 1294713
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Clozapine 12.5 MG 405960

Showing up to 8 concepts per family — 10 of 10 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Clozapine 12.5 MG SCDC · 405960
  • Clozapine Disintegrating Oral Tablet SCDF · 476178
  • Clozapine Disintegrating Oral Product SCDG · 1295568
  • Clozapine Oral Product SCDG · 1153930
  • Clozapine Pill SCDG · 1153931

📦 FDA Products & Package NDCs

10 products · 18 package NDCs
18 package NDCs map to RxCUI 721773 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00093-5376-01 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (0093-5376-01) Clozapine Teva Pharmaceuticals USA, Inc. 2020-07-30
00093-5376-84 48 BLISTER PACK in 1 CARTON (0093-5376-84) / 1 TABLET, ORAL... Clozapine Teva Pharmaceuticals USA, Inc. 2021-09-01
00093-5377-01 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (0093-5377-01) Clozapine Teva Pharmaceuticals USA, Inc. 2020-07-30
00093-5377-84 48 BLISTER PACK in 1 CARTON (0093-5377-84) / 1 TABLET, ORAL... Clozapine Teva Pharmaceuticals USA, Inc. 2020-07-30
00093-5416-01 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (0093-5416-01) Clozapine Teva Pharmaceuticals USA, Inc. 2018-04-17
00093-5417-01 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (0093-5417-01) Clozapine Teva Pharmaceuticals USA, Inc. 2017-07-25
00093-5417-84 48 BLISTER PACK in 1 CARTON (0093-5417-84) / 1 TABLET, ORAL... Clozapine Teva Pharmaceuticals USA, Inc. 2017-07-25
00093-5419-01 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (0093-5419-01) Clozapine Teva Pharmaceuticals USA, Inc. 2017-07-25
00093-5419-84 48 BLISTER PACK in 1 CARTON (0093-5419-84) / 1 TABLET, ORAL... Clozapine Teva Pharmaceuticals USA, Inc. 2017-07-25
59651-0260-01 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (59651-260-01) Clozapine Aurobindo Pharma Limited 2024-12-12
59651-0261-01 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (59651-261-01) Clozapine Aurobindo Pharma Limited 2024-12-12
59651-0261-48 8 BLISTER PACK in 1 CARTON (59651-261-48) / 6 TABLET, ORALL... Clozapine Aurobindo Pharma Limited 2024-12-12
59651-0262-01 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (59651-262-01) Clozapine Aurobindo Pharma Limited 2024-12-12
59651-0262-48 8 BLISTER PACK in 1 CARTON (59651-262-48) / 6 TABLET, ORALL... Clozapine Aurobindo Pharma Limited 2024-12-12
59651-0263-01 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (59651-263-01) Clozapine Aurobindo Pharma Limited 2024-12-12
59651-0263-48 8 BLISTER PACK in 1 CARTON (59651-263-48) / 6 TABLET, ORALL... Clozapine Aurobindo Pharma Limited 2024-12-12
59651-0264-01 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (59651-264-01) Clozapine Aurobindo Pharma Limited 2024-12-12
59651-0264-48 8 BLISTER PACK in 1 CARTON (59651-264-48) / 6 TABLET, ORALL... Clozapine Aurobindo Pharma Limited 2024-12-12
Observed labelers: Aurobindo Pharma Limited (9) · Teva Pharmaceuticals USA, Inc. (9) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.